# Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome

> **NCT02112253** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **The University of Western Australia**

## Conditions studied

- Tourette's Syndrome

## Interventions

- **DEVICE:** Deep brain stimulator ventral electrode up to 2 mA
- **DEVICE:** Deep brain stimulator ventral electrode up to 3 mA
- **DEVICE:** Deep brain stimulator dorsal electrode up to 2 mA
- **DEVICE:** Deep brain stimulator dorsal electrode up to 3 mA
- **DEVICE:** Deep brain stimulator empirical programming

## Key facts

- **NCT ID:** NCT02112253
- **Lead sponsor:** The University of Western Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2021-05-14
- **Final completion:** 2021-05-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2021-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02112253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02112253, "Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02112253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*